Evidence map›Paper›PMID 35026479›Full record

ArticleRespiratory physiology & neurobiology2022

Noninvasive ventilation and high-flow nasal cannula in patients with acute hypoxemic respiratory failure by covid-19: A retrospective study of the feasibility, safety and outcomes.

Wesla Neves da Silva Costa, Juliana Padovezi Miguel, Fabiana Dos Santos Prado, Liz Helena Santos de Mello Lula, Gustavo Adolpho Junqueira Amarante, Renato Fraga Righetti, Wellington Pereira Yamaguti

Open access · hybridAbstract read
In one paragraph

Article in Respiratory physiology & neurobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Effectiveness of high-flow nasal cannula therapy on clinical outcomes in adults with COVID-19: A systematic review.Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR · 2023
    Review
  12. Supportive Care in Patients with Critical Coronavirus Disease 2019.Infectious disease clinics of North America · 2022
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Wesla Neves da Silva CostaHospital Sírio-Libanês, São Paulo, Brazil. Electronic address: wesla.nsilva@hsl.org.br.
Juliana Padovezi MiguelHospital Sírio-Libanês, São Paulo, Brazil. Electronic address: juliana.pmiguel@hsl.org.br.
Fabiana Dos Santos PradoHospital Sírio-Libanês, São Paulo, Brazil. Electronic address: fabiana.sprado@hsl.org.br.
Liz Helena Santos de Mello LulaHospital Sírio-Libanês, São Paulo, Brazil. Electronic address: liz.hsmlula@hsl.org.br.
Gustavo Adolpho Junqueira AmaranteHospital Sírio-Libanês, São Paulo, Brazil. Electronic address: gustavo.amarante@hsl.org.br.
Renato Fraga RighettiHospital Sírio-Libanês, São Paulo, Brazil. Electronic address: refragar@gmail.com.
Wellington Pereira YamagutiHospital Sírio-Libanês, São Paulo, Brazil. Electronic address: wellington.psyamaguti@hsl.org.br.
Hospital Sírio-Libanês · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNoninvasive ventilation (NIV) and High-flow nasal cannula (HFNC) are the main forms of treatment for acute respiratory failure. This study aimed to evaluate the effect, safety, and applicability of the NIV and HFNC in patients with acute hypoxemic respiratory failure (AHRF) caused by COVID-19.

methodsIn this retrospective study, we monitored the effect of NIV and HFNC on the SpO

results62.2 % of patients were treated with HFNC. ROX index increased during and after NIV and HFNC treatment (P < 0.05). SpO

conclusionThe application of NIV and HFNC in the critical care unit is feasible and associated with favorable outcomes. In addition, there was no increase in the infection of physiotherapists with SARS-CoV-2.

Indexed as

CannulaIntubation, IntratrachealNoninvasive VentilationOutcome and Process Assessment, Health CarePositive-Pressure RespirationAcute DiseaseAdministration, InhalationAdultAgedAged, 80 and overBrazilCOVID-19Feasibility StudiesFemaleHumansIntensive Care UnitsOxygenAcute respiratory failureCOVID-19High-flow nasal cannulaNoninvasive ventilationSARS-CoV-2

Identifiers

PMID35026479
PMCPMC8744300
OpenAlexW4206055493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.